Corcept Therapeutics Incorporated (NASDAQ:CORT) Looks Just Right With A 30% Price Jump

Simply Wall StNov 9 21:23

Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy?

Zacks Nov 6 19:00

Truist Financial Maintains Corcept Therapeutics(CORT.US) With Buy Rating

Futu NewsNov 4 20:35 · Ratings

Truist Financial Keeps Their Buy Rating on Corcept Therapeutics (CORT)

TipRanksNov 4 20:16 · Ratings

Earnings Call: Corcept Therapeutics Reports Robust Q3 Growth, Raises Guidance

InvestingNov 1 01:46

A Quick Look at Today's Ratings for Corcept Therapeutics(CORT.US), With a Forecast Between $67 to $80

Futu NewsOct 31 21:00 · Ratings